共 48 条
Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy
被引:82
作者:
Lu, Qing-Bo
[1
,2
]
Ding, Yi
[3
]
Liu, Yao
[4
]
Wang, Zi-Chao
[5
]
Wu, Yu-Jie
[5
]
Niu, Kai -Ming
[5
]
Li, Ke-Xue
[6
]
Zhang, Ji -Ru
[3
]
Sun, Hai-Jian
[1
,5
,7
]
机构:
[1] Jiangnan Univ, Wuxi Sch Med, Dept Basic Med, Wuxi 214122, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Endocrine, Wuxi 214125, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Dept Anesthesiol, Wuxi 214125, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 4, Dept Cardiac Ultrasound, Nanjing 210000, Jiangsu, Peoples R China
[5] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Peoples R China
[6] Xuzhou Med Univ, Dept Physiol, 209 Tongshan Rd, Xuzhou 221004, Peoples R China
[7] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore
基金:
中国国家自然科学基金;
关键词:
Diabetes;
Cardiomyopathy;
Metrnl;
AMPK;
Autophagy;
STING;
PHOSPHORYLATION;
D O I:
10.1016/j.jare.2022.10.014
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Introduction: Meteorin-like hormone (Metrnl) is ubiquitously expressed in skeletal muscle, heart, and adipose with beneficial roles in obesity, insulin resistance, and inflammation. Metrnl is found to protect against cardiac hypertrophy and doxorubicin-induced cardiotoxicity. However, its role in diabetic cardiomyopathy (DCM) is undefined.Objectives: We aimed to elucidate the potential roles of Metrnl in DCM.Methods: Gain-and loss-of-function experiments were utilized to determine the roles of Metrnl in the pathological processes of DCM. Results: We found that plasma Metrnl levels, myocardial Metrnl protein and mRNA expressions were significantly downregulated in both streptozotocin (STZ)-induced (T1D) mice and leptin receptor deficiency (db/db) (T2D) mice. Cardiac-specific overexpression (OE) of Metrnl markedly ameliorated cardiac injury and dysfunction in both T1D and T2D mice. In sharp contrast, specific deletion of Metrnl in the heart had the opposite phenotypes. In parallel, Metrnl OE ameliorated, whereas Metrnl downregulation exacerbated high glucose (HG)-elicited hypertrophy, apoptosis and oxidative damage in primary neonatal rat cardiomyocytes. Antibody-induced blockade of Metrnl eliminated the effects of benefits of Metrnl in vitro and in vivo. Mechanistically, Metrnl activated the autophagy pathway and inhibited the cGAS/ STING signaling in a LKB1/AMPK/ULK1-dependent mechanism in cardiomyocytes. Besides, Metrnlinduced ULK1 phosphorylation facilitated the dephosphorylation and mitochondrial translocation of STING where it interacted with tumor necrosis factor receptor-associated factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase that was responsible for ubiquitination and degradation of STING, rendering cardiomyocytes sensitive to autophagy activation.Conclusion: Thus, Metrnl may be an attractive therapeutic target or regimen for treating DCM.(c) 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:161 / 179
页数:19
相关论文